ID   GHR_RAT                 Reviewed;         638 AA.
AC   P16310; Q64236; Q80XW9;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 1.
DT   02-OCT-2024, entry version 191.
DE   RecName: Full=Growth hormone receptor {ECO:0000303|PubMed:2722883};
DE            Short=GH receptor;
DE   AltName: Full=Somatotropin receptor;
DE   Contains:
DE     RecName: Full=Growth hormone-binding protein;
DE              Short=GH-binding protein;
DE              Short=GHBP;
DE     AltName: Full=Serum-binding protein;
DE   Flags: Precursor;
GN   Name=Ghr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Liver;
RX   PubMed=2722883; DOI=10.1016/s0021-9258(18)81745-8;
RA   Mathews L.S., Enberg B., Norstedt G.;
RT   "Regulation of rat growth hormone receptor gene expression.";
RL   J. Biol. Chem. 264:9905-9910(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ISOFORMS 1 AND 2).
RX   PubMed=2792761; DOI=10.1101/gad.3.8.1199;
RA   Baumbach W.R., Horner D.L., Logan J.S.;
RT   "The growth hormone-binding protein in rat serum is an alternatively
RT   spliced form of the rat growth hormone receptor.";
RL   Genes Dev. 3:1199-1205(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Adipose tissue;
RX   PubMed=1446642; DOI=10.1210/endo.131.6.1446642;
RA   Frick G.P., Goodman H.M.;
RT   "Characterization of the short isoform of the growth hormone receptor
RT   synthesized by rat adipocytes.";
RL   Endocrinology 131:3083-3090(1992).
RN   [4]
RP   PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2).
RX   PubMed=8921876; DOI=10.1016/0378-1119(96)00277-6;
RA   Zhou Y., He L., Kopchick J.J.;
RT   "Structural comparison of a portion of the rat and mouse growth hormone
RT   receptor/binding protein genes.";
RL   Gene 177:257-259(1996).
RN   [5]
RP   DOMAIN JAK2 BINDING.
RX   PubMed=8063815; DOI=10.1016/s0021-9258(17)31863-x;
RA   VanderKuur J.A., Wang X., Zhang L., Campbell G.S., Allevato G.,
RA   Billestrup N., Norstedt G., Carter-Su C.;
RT   "Domains of the growth hormone receptor required for association and
RT   activation of JAK2 tyrosine kinase.";
RL   J. Biol. Chem. 269:21709-21717(1994).
RN   [6]
RP   ENDOCYTOSIS SIGNAL, AND MUTAGENESIS OF PHE-346.
RX   PubMed=7615519; DOI=10.1074/jbc.270.29.17210;
RA   Allevato G., Billestrup N., Goujon L., Galsgaard E.D., Norstedt G.,
RA   Postel-Vinay M.-C., Kelly P.A., Nielsen J.H.;
RT   "Identification of phenylalanine 346 in the rat growth hormone receptor as
RT   being critical for ligand-mediated internalization and down-regulation.";
RL   J. Biol. Chem. 270:17210-17214(1995).
RN   [7]
RP   INTERACTION WITH SOCS FAMILY PROTEINS.
RX   PubMed=10585430; DOI=10.1074/jbc.274.50.35553;
RA   Ram P.A., Waxman D.J.;
RT   "SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling
RT   by multiple mechanisms.";
RL   J. Biol. Chem. 274:35553-35561(1999).
RN   [8]
RP   PHOSPHORYLATION BY JAK2.
RX   PubMed=7545168; DOI=10.1074/jbc.270.37.21738;
RA   VanderKuur J.A., Wang X., Zhang L., Allevato G., Billestrup N.,
RA   Carter-Su C.;
RT   "Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the
RT   growth hormone receptor.";
RL   J. Biol. Chem. 270:21738-21744(1995).
RN   [9]
RP   PHOSPHORYLATION, AND FUNCTION.
RX   PubMed=9231797; DOI=10.1210/endo.138.8.5332;
RA   Smit L.S., Vanderkuur J.A., Stimage A., Han Y., Luo G., Yu-Lee L.-Y.,
RA   Schwartz J., Carter-Su C.;
RT   "Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid
RT   binding activity of Stat5A and Stat5B.";
RL   Endocrinology 138:3426-3434(1997).
RN   [10]
RP   FUNCTION.
RX   PubMed=11244571; DOI=10.1089/107999001750069935;
RA   Hellgren G., Albertsson-Wikland K., Billig H., Carlsson L.M., Carlsson B.;
RT   "Growth hormone receptor interaction with Jak proteins differs between
RT   tissues.";
RL   J. Interferon Cytokine Res. 21:75-83(2001).
CC   -!- FUNCTION: Receptor for pituitary gland growth hormone involved in
CC       regulating postnatal body growth (PubMed:11244571). On ligand binding,
CC       couples to, and activates the JAK2/STAT5 pathway (PubMed:11244571,
CC       PubMed:9231797). {ECO:0000269|PubMed:11244571,
CC       ECO:0000269|PubMed:9231797}.
CC   -!- FUNCTION: Receptor for pituitary gland growth hormone (GH1) involved in
CC       regulating postnatal body growth. On ligand binding, couples to the
CC       JAK2/STAT5 pathway. {ECO:0000250|UniProtKB:P10912}.
CC   -!- FUNCTION: [Growth hormone-binding protein]: The soluble form (GHBP)
CC       acts as a reservoir of growth hormone in plasma and may be a
CC       modulator/inhibitor of GH signaling. {ECO:0000250|UniProtKB:P10912}.
CC   -!- SUBUNIT: On growth hormone (GH) binding, forms homodimers and binds
CC       JAK2 via a box 1-containing domain. {ECO:0000250|UniProtKB:P10912}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P10912};
CC       Single-pass type I membrane protein {ECO:0000255}. Note=On growth
CC       hormone binding, GHR is ubiquitinated, internalized, down-regulated and
CC       transported into a degradative or non-degradative pathway.
CC       {ECO:0000250|UniProtKB:P19941}.
CC   -!- SUBCELLULAR LOCATION: [Growth hormone-binding protein]: Secreted
CC       {ECO:0000250|UniProtKB:P10912}. Note=Complexed to a substantial
CC       fraction of circulating GH. {ECO:0000250|UniProtKB:P10912}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P16310-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short from, GHBP;
CC         IsoId=P16310-2; Sequence=VSP_010231, VSP_010232;
CC   -!- TISSUE SPECIFICITY: Highest expression in liver (PubMed:2722883). Also
CC       expressed in heart, kidney and muscle (PubMed:2722883).
CC       {ECO:0000269|PubMed:2722883}.
CC   -!- DEVELOPMENTAL STAGE: Expression is low at birth (PubMed:2722883).
CC       Increases to adult levels after 5 weeks (PubMed:2722883).
CC       {ECO:0000269|PubMed:2722883}.
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-surface
CC       receptor binding. {ECO:0000269|PubMed:8063815}.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation. {ECO:0000269|PubMed:8063815}.
CC   -!- DOMAIN: The extracellular domain is the ligand-binding domain
CC       representing the growth hormone-binding protein (GHBP).
CC       {ECO:0000269|PubMed:8063815}.
CC   -!- DOMAIN: The ubiquitination-dependent endocytosis motif (UbE) is
CC       required for recruitment of the ubiquitin conjugation system on to the
CC       receptor and for its internalization. {ECO:0000269|PubMed:8063815}.
CC   -!- PTM: The soluble form (GHBP) is produced by phorbol ester-promoted
CC       proteolytic cleavage at the cell surface (shedding) by ADAM17/TACE (By
CC       similarity). Shedding is inhibited by growth hormone (GH) binding to
CC       the receptor probably due to a conformational change in GHR rendering
CC       the receptor inaccessible to ADAM17 (By similarity).
CC       {ECO:0000250|UniProtKB:P10912, ECO:0000250|UniProtKB:P19941}.
CC   -!- PTM: On GH binding, phosphorylated on tyrosine residues in the
CC       cytoplasmic domain by JAK2 (PubMed:7545168, PubMed:9231797).
CC       Phosphorylation on either (or all of) Tyr-534, Tyr-566 and/or Tyr-627
CC       is required for STAT5 activation. Phosphorylation on Tyr-333 would seem
CC       necessary for JAK2 activation (PubMed:7545168, PubMed:9231797).
CC       {ECO:0000269|PubMed:7545168, ECO:0000269|PubMed:9231797}.
CC   -!- PTM: Ubiquitinated by the ECS(SOCS2) complex following ligand-binding
CC       and phosphorylation by JAK2, leading to its degradation by the
CC       proteasome. Regulation by the ECS(SOCS2) complex acts as a negative
CC       feedback loop of growth hormone receptor signaling (By similarity).
CC       Ubiquitination is not sufficient for GHR internalization (By
CC       similarity). {ECO:0000250|UniProtKB:P10912,
CC       ECO:0000250|UniProtKB:P19941}.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J04811; AAA41219.1; -; mRNA.
DR   EMBL; S49003; AAP13886.1; -; mRNA.
DR   EMBL; U44722; AAC52916.1; -; Genomic_DNA.
DR   PIR; A32985; A33505.
DR   PIR; B32985; B32985.
DR   RefSeq; NP_058790.1; NM_017094.1. [P16310-1]
DR   RefSeq; XP_008758976.1; XM_008760754.1. [P16310-1]
DR   AlphaFoldDB; P16310; -.
DR   SMR; P16310; -.
DR   BioGRID; 247275; 1.
DR   DIP; DIP-63N; -.
DR   IntAct; P16310; 3.
DR   MINT; P16310; -.
DR   STRING; 10116.ENSRNOP00000044119; -.
DR   DrugCentral; P16310; -.
DR   GuidetoPHARMACOLOGY; 1720; -.
DR   GlyCosmos; P16310; 4 sites, No reported glycans.
DR   GlyGen; P16310; 4 sites.
DR   iPTMnet; P16310; -.
DR   PhosphoSitePlus; P16310; -.
DR   PaxDb; 10116-ENSRNOP00000044119; -.
DR   Ensembl; ENSRNOT00000021081.7; ENSRNOP00000021081.6; ENSRNOG00000015654.9. [P16310-2]
DR   Ensembl; ENSRNOT00000046951.6; ENSRNOP00000044119.3; ENSRNOG00000015654.9. [P16310-1]
DR   Ensembl; ENSRNOT00055010221; ENSRNOP00055007905; ENSRNOG00055006301. [P16310-1]
DR   Ensembl; ENSRNOT00060025110; ENSRNOP00060020002; ENSRNOG00060014684. [P16310-1]
DR   Ensembl; ENSRNOT00065036606; ENSRNOP00065029470; ENSRNOG00065021537. [P16310-1]
DR   GeneID; 25235; -.
DR   KEGG; rno:25235; -.
DR   AGR; RGD:2687; -.
DR   CTD; 2690; -.
DR   RGD; 2687; Ghr.
DR   eggNOG; KOG3555; Eukaryota.
DR   GeneTree; ENSGT00940000159987; -.
DR   HOGENOM; CLU_022322_0_0_1; -.
DR   InParanoid; P16310; -.
DR   OMA; YKPQLYN; -.
DR   OrthoDB; 5317462at2759; -.
DR   PhylomeDB; P16310; -.
DR   Reactome; R-RNO-1170546; Prolactin receptor signaling.
DR   Reactome; R-RNO-982772; Growth hormone receptor signaling.
DR   PRO; PR:P16310; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000015654; Expressed in liver and 18 other cell types or tissues.
DR   ExpressionAtlas; P16310; baseline and differential.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0070195; C:growth hormone receptor complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0019955; F:cytokine binding; IBA:GO_Central.
DR   GO; GO:0019838; F:growth factor binding; ISO:RGD.
DR   GO; GO:0004903; F:growth hormone receptor activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; ISO:RGD.
DR   GO; GO:0017046; F:peptide hormone binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IDA:BHF-UCL.
DR   GO; GO:0019903; F:protein phosphatase binding; IMP:RGD.
DR   GO; GO:0042169; F:SH2 domain binding; IDA:RGD.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEP:RGD.
DR   GO; GO:0007259; P:cell surface receptor signaling pathway via JAK-STAT; IDA:BHF-UCL.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; ISO:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0060396; P:growth hormone receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0042445; P:hormone metabolic process; ISO:RGD.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IDA:RGD.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IEP:RGD.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IDA:BHF-UCL.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0046427; P:positive regulation of receptor signaling pathway via JAK-STAT; IDA:RGD.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:0032107; P:regulation of response to nutrient levels; IMP:RGD.
DR   GO; GO:0034097; P:response to cytokine; IEP:RGD.
DR   GO; GO:0032094; P:response to food; IEP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0009629; P:response to gravity; IEP:RGD.
DR   GO; GO:0060416; P:response to growth hormone; IEP:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0070555; P:response to interleukin-1; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0019530; P:taurine metabolic process; ISO:RGD.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR025871; GHBP.
DR   InterPro; IPR015152; Growth/epo_recpt_lig-bind.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003528; Long_hematopoietin_rcpt_CS.
DR   InterPro; IPR050379; Type-I_Cytokine_Rcpt.
DR   PANTHER; PTHR23036; CYTOKINE RECEPTOR; 1.
DR   PANTHER; PTHR23036:SF108; GROWTH HORMONE RECEPTOR; 1.
DR   Pfam; PF09067; EpoR_lig-bind; 1.
DR   Pfam; PF12772; GHBP; 1.
DR   SUPFAM; SSF49265; Fibronectin type III; 2.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS01352; HEMATOPO_REC_L_F1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Endocytosis;
KW   Glycoprotein; Membrane; Phosphoprotein; Receptor; Reference proteome;
KW   Secreted; Signal; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..638
FT                   /note="Growth hormone receptor"
FT                   /id="PRO_0000010969"
FT   CHAIN           19..256
FT                   /note="Growth hormone-binding protein"
FT                   /evidence="ECO:0000250|UniProtKB:P19941"
FT                   /id="PRO_0000010970"
FT   TOPO_DOM        19..265
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        266..289
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        290..638
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          151..254
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          295..380
FT                   /note="Required for JAK2 binding"
FT                   /evidence="ECO:0000269|PubMed:8063815"
FT   REGION          357..389
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           240..244
FT                   /note="WSXWS motif"
FT                   /evidence="ECO:0000250|UniProtKB:P10912"
FT   MOTIF           298..306
FT                   /note="Box 1 motif"
FT                   /evidence="ECO:0000269|PubMed:8063815"
FT   MOTIF           341..350
FT                   /note="UbE motif"
FT                   /evidence="ECO:0000305|PubMed:7615519"
FT   COMPBIAS        360..389
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         342
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P10912"
FT   MOD_RES         487
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P10912"
FT   MOD_RES         594
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P10912"
FT   CARBOHYD        115
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        156
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        161
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        200
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        56..66
FT                   /evidence="ECO:0000250|UniProtKB:P10912"
FT   DISULFID        101..112
FT                   /evidence="ECO:0000250|UniProtKB:P10912"
FT   DISULFID        126..140
FT                   /evidence="ECO:0000250|UniProtKB:P10912"
FT   VAR_SEQ         263..279
FT                   /note="DFRFPWFLIIIFGIFGV -> GPKFNSQHPHQEIDNHL (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:1446642"
FT                   /id="VSP_010231"
FT   VAR_SEQ         280..638
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1446642"
FT                   /id="VSP_010232"
FT   MUTAGEN         346
FT                   /note="F->A: No internalization nor down-regulation. No
FT                   effect on transcriptional signaling."
FT                   /evidence="ECO:0000269|PubMed:7615519"
SQ   SEQUENCE   638 AA;  71237 MW;  0D8E9AF759A21A3B CRC64;
     MDLWRVFLTL ALAVSSDMFP GSGATPATLG KASPVLQRIN PSLRESSSGK PRFTKCRSPE
     LETFSCYWTE GDDHNLKVPG SIQLYYARRI AHEWTPEWKE CPDYVSAGAN SCYFNSSYTS
     IWIPYCIKLT TNGDLLDEKC FTVDEIVQPD PPIGLNWTLL NISLPGIRGD IQVSWQPPPS
     ADVLKGWIIL EYEIQYKEVN ETKWKTMSPI WSTSVPLYSL RLDKEHEVRV RSRQRSFEKY
     SEFSEVLRVT FPQMDTLAAC EEDFRFPWFL IIIFGIFGVA VMLFVVIFSK QQRIKMLILP
     PVPVPKIKGI DPDLLKEGKL EEVNTILGIH DNYKPDFYND DSWVEFIELD IDDADEKTEE
     SDTDRLLSDD QEKSAGILGA KDDDSGRTSC YDPDILDTDF HTSDMCDGTS EFAQPQKLKA
     EADLLCLDQK NLKNSPYDAS LGSLHPSITL TMEDKPQPLL GSETESTHQL PSTPMSSPVS
     LANIDFYAQV SDITPAGGVV LSPGQKIKAG LAQGNTQLEV AAPCQENYSM NSAYFCESDA
     KKCIAAAPHM EATTCVKPSF NQEDIYITTE SLTTTARMSE TADTAPDAEP VPDYTTVHTV
     KSPRGLILNA TALPLPDKKK FLSSCGYVST DQLNKIMQ
//
